Skin checking app Miiskin, which supports the work of the British Skin Foundation, is has been listed on the EMIS App Library and recommended by GPs and other primary care clinicians.
The app, which was developed to encourage people to be more aware of changes to their skin, has also gone live on the NHS Apps Library.
EMIS Health and IQVIA, a global leader in human data science, have collaborated to enable 58% of GPs in England to electronically recommend Miiskin. The app, which recently made artificial intelligence (AI) skin mapping available via consumer technology, can be recommended to patients using EMIS App Library by AppScript.
EMIS App Library provides clinicians with a list of digital health apps they can electronically recommend to patients directly from their existing EMIS Web workflows. All the apps in the library have been reviewed using NHS Digital’s Digital Assessment Questions (DAQ) framework or have been recommended or commissioned by local NHS authorities. The DAQ framework, which is also used for populating apps in the NHS Apps Library, includes criteria against:
- Effectiveness
- Clinical safety
- Data protection
- Security
- Usability and accessibility
- Interoperability
- Technical stability
When GPs recommend apps to patients using EMIS App Library, they receive a download link via text or email. So far, more than 60% of patients recommended an app via the platform click through to install or enrol for the app.
Miiskin was developed to help people digitally track changes to existing moles, as well as new moles and marks using AI skin mapping to help detect early warning signs of skin cancer. Since it was launched, the app has had 500,000 downloads globally and 65,000 in the UK. It does not try to diagnose skin cancer or tell users that they are at risk or not. Those who do spot changes are encouraged to seek advice from their GP or specialist.
The app is supported by dermatologists with 93% the Skin Health Alliance 2019 Survey saying patients’ use of photographic records of moles and wider areas of the skin was a good way of monitoring the skin and moles for changes.
Jon Friis, founder and CEO of Miiskin said: “We are delighted that Miiskin has been listed on the EMIS App Library for GP referral, as well as the NHS Apps Library.
“The app enables users to track their skin and present photographic evidence to clinicians if they notice concerning changes. Unlike other apps, Miiskin doesn’t aim to encourage patients to self-diagnose.”
Brian Clancy, associate director, IQVIA and responsible for AppScript, added: “We believe that high quality digital health apps work best for all parties when recommended by clinicians using workflow-integrated tools such as EMIS App Library by AppScript. We’re highly selective in which apps are included within the library. We welcome Miiskin in joining us in our mission to help clinicians connect the right patients to the right digital therapeutics at the right time.”
